(b)(4).The udi is unknown because the part and lot numbers were not provided.The incident information was reviewed; however, there was no reported device malfunction and the product was not returned.A review of the lot history record of the reported device could not be conducted because the part and lot numbers were not provided.The reported patient effects of hypersensitivity and rash are listed in instructions for use xience alpine everolimus eluting coronary stent systems as a known patient effects)of coronary stenting procedures.A conclusive cause for the reported patient effects and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
|
It was reported the procedure was performed on an un-specified date, approximately 3 months ago.This was a stemi patient.The xience alpine stent was implanted without issue.The patient returned 1-2 months after the initial procedure with a rash due to a nickel allergy from the implanted stent.The patient was given medication for treatment.The patient is currently stable; however, the rash did not resolve.No further treatment has been performed.No additional information was provided.
|